MedPath

Efficacy of Prevention for Postoperative Nausea and Vomiting After Intrathecal Morphine in Cesarean Section

Not Applicable
Conditions
Pregnancy
PONV
Interventions
Registration Number
NCT00892996
Lead Sponsor
Mahidol University
Brief Summary

Post-operative nausea and vomiting are the major complications after spinal anesthesia with intrathecal morphine, therefore antiemetic drugs should be administered for best satisfaction of anesthesia to prevent these complication.

Furthermore, administration of a combination of antiemetic drugs with different mechanisms of action appears reasonable and synergistic effect of drugs.

In conclusion, we study efficacy of antiemetic effect of single antiemetic drug compare with combination antiemetic drugs.

Detailed Description

In this study : a randomized, double-blind, placebo-controlled, clinical trial comparing single doses of Metoclopramide 10 mg and Ondansetron 8 mg alone and a combination of Dexamethasone 5 mg and Metoclopramide 10 mg or a combination of Dexamethasone 5 mg and Ondansetron 8 mg for prevention of PONV after spinal morphine for cesarean section.

Inclusion criteria

1. Patient undergoes elective cesarean section age more than 18 years

2. Patient accepted in spinal anesthesia technique

3. ASA classification I-II

4. Patient understand question and evaluation process

Exclusion criteria

1. Hyperemesis gravidarum

2. Patient with ongoing antiemetic drugs treatment

3. Patient with history of drug allergy in Metoclopramide,Ondansetron and Dexamethasone

Outcome measurement By oral interview and nurse notification in 24 hr. post-operatively.

Detail of outcome measurement

1. Nausea and vomiting score

2. Pain score

3. Sedation score

4. Itch symptom

5. Patient satisfaction

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
120
Inclusion Criteria
  • Pregnancy patients undergo Elective cesarean section age more than 18 years
  • Patient accept spinal anesthesia technique
  • ASA classification I-II
  • Patient understand question and evaluation process

Exclusion criteria:

  • Hyperemesis gravidarum
  • Patient ongoing treatment with antiemetic drugs
  • Allergy to Metoclopramide,Ondansetron and Dexamethasone
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
3dexamethasonedexamethasone 5 mg and metoclopramide 10 mg
4dexamethasone 5 mgdexamethasone 5 mg and ondansetron 8 mg IV
Primary Outcome Measures
NameTimeMethod
nausea and vomiting after spinal anesthesia with intrathecal morphine in cesarean section24 hrs post operatively
Secondary Outcome Measures
NameTimeMethod
Secondary outcome measurement 1. Sedation score 2. Pain score 3. Itching symptom 4. Patient satisfaction24 Hrs post operatively

Trial Locations

Locations (1)

Anesthesiology department, Siriraj hospital, Mahidol University

🇹🇭

Bangkok, Thailand

© Copyright 2025. All Rights Reserved by MedPath